AzTrials
AzTrials

Temporomandibular Disorders (TMD)TMD/VAS/ROMNCT06994910

Temporomandibular Disorders Physiotherapy

A study testing Maitland mobilization techniques in people with Temporomandibular Disorders (TMD), run by Palestine Polytechnic University at 1 site in Palestinian Territories.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aims to investigate the effectiveness of the Maitland joint mobilization technique in alleviating symptoms related to (temporomandibular disorders) TMD and to investigate its influence on patient clinical outcomes, including pain intensity, TMJ range of motion (ROM), functional limitations, disability, and… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Temporomandibular Disorders (TMD)
What is being tested?
Maitland mobilization techniques
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 sitePalestinian Territories
Study dates
7 Aug 2023to 24 Dec 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Diagnosis: individuals diagnosed with TMD, whether it is unilateral or bilateral.
  • Myofascial pain and myo-spasm.
  • Anterior disk displacement with reduction and anterior disk displacement without reduction.
  • Craniofacial and craniomandibular pain.
  • Myofascial pain with or without limited mouth opening.

Who cannot join

  • Patients with a documented history of surgical procedures involving the TMJ.
  • Patients with a confirmed diagnosis of systemic diseases (e.g., rheumatic and metabolic diseases).
  • Patients with congenital or developmental craniofacial anomalies, including conditions like as ankylosis.
  • Patients with diagnosed cancer.
  • Patients with mental, physical disorders and language difficulties.
  • Patients with diagnosed neuropathic and dental pain.
  • Patients with diagnosed general myopathy (e.g., fibromyalgia).

Trial locations and contacts

1 site in 1 country.

Palestinian Territories1 site
  • Palestine Polytechnic University

    Hebron

Other trials in Palestinian Territories

About this study

Official title: Investigation Into the Effectiveness of Maitland Joint Mobilization in Alleviating Symptoms of Temporomandibular Disorders, Enhancing Joint Function, and Oral Behaviors

This study aims to investigate the effectiveness of the Maitland joint mobilization technique in alleviating symptoms related to (temporomandibular disorders) TMD and to investigate its influence on patient clinical outcomes, including pain intensity, TMJ range of motion (ROM), functional limitations, disability, and oral behaviors.

Read the detailed description

Physiotherapeutic procedures for TMD aim to reduce pain, enhance neuromuscular coordination and strength, and promote joint range of motion (ROM), mastication, mouth opening, and general mobility. The literature highlights a variety of physiotherapy techniques used to treat TMD, including manual therapy, stretching, active and passive exercises, as well as modalities like thermotherapy, ultrasound, electrotherapy, iontophoresis, laser therapy, shockwave therapy, infrared therapy, kinesiology taping, and dry needling. Clinical research supports the efficacy of physiotherapy as a conservative treatment for TMD, effectively addressing pain, muscular dysfunctions, and psychosocial factors. Optimal results are achieved through a combination of therapeutic exercises and manual therapy, which is considered one of the most effective approaches.

The Maitland joint mobilization technique is a key physiotherapeutic procedure for managing TMD. This technique involves passive, rhythmic joint mobilizations aimed at restoring joint functionality and alleviating pain. The technique employs five grades of mobility, each designed for specific therapeutic goals. Grades I and II are used to reduce pain and relax soft tissues, while Grades III, IV, and V focus on addressing joint hypomobility by stretching soft tissues and improving joint mobility. The technique enhances both osteokinematic and arthrokinematic movements, with osteokinematic referring to voluntary joint motion, and arthrokinematic to the small, involuntary movements that occur during normal joint ROM. Maitland joint mobilization utilizes controlled forces in specific directions, based on Kaltenborn's concave-convex rule, to optimize both movements and improve joint function. This research is essential for providing further evidence that supports enhanced physiotherapeutic techniques, resulting in enhancing patient clinical outcomes and enhancing professional practices for the optimal management of TMD.

Being tested
Maitland mobilization techniques
Keywords
Temporomandibular Disorders, Physiotherapy, Maitland Mobilization Technique
Medical subject headings
Temporomandibular Joint Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Maitland mobilization techniquesOther

    Participants with temporomandibular joint dysfunction received Maitland mobilization techniques applied to the TMJ over a defined treatment period. Outcomes were assessed at baseline (pre-intervention) and after completion of the intervention (post-intervention)

Study groups in NCT06994910
Study groupRoleWhat they receive
Before Maitland joint mobilizationExperimentalParticipants with temporomandibular joint dysfunction received Maitland mobilization techniques applied to the TMJ over a defined treatment period. Outcomes were assessed at baseline (pre-intervention) and after completion of the intervention (post-intervention)
Receives: Other: Maitland mobilization techniques
After Maitland joint mobilizationExperimentalParticipants with temporomandibular joint dysfunction received Maitland mobilization techniques applied to the TMJ over a defined treatment period. Outcomes were assessed at baseline (pre-intervention) and after completion of the intervention (post-intervention).
Receives: Other: Maitland mobilization techniques

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain intensity

    Pain intensity will be assessed using a 10-centimeter Visual Analogue Scale (VAS), where 0 represents "no pain" and 10 represents "worst imaginable pain." Participants will be asked to indicate the average intensity of their jaw-related pain experienced over the past week. This tool is used to evaluate the effect of the intervention on subjective pain levels in patients diagnosed with temporomandibular disorders.

    Measured: Pain will be measured at baseline (pre-intervention) and after completion of the 4-week intervention (post-intervention)

  2. Temporomandibular joint range of motion

    The range of motion (ROM) of the temporomandibular joint will be measured using the TheraBiteⓇ Range of Motion Scales, a standardized tool designed to accurately assess mandibular movements including maximum mouth opening, lateral excursion, and protrusion. Measurements will be taken in millimeters by trained assessors to evaluate functional improvement following the intervention in patients with temporomandibular disorders.

    Measured: Temporomandibular joint range of motion will be assessed at baseline (pre-intervention) and after the 4-week intervention (post-intervention).

  3. Jaw functional disability

    Jaw functional disability will be evaluated using the Jaw Functional Limitation Scale (JFLS-20), a validated and reliable questionnaire designed to assess limitations in jaw function across three domains: mastication, jaw movements, and verbal communication. Patients will self-report the degree of difficulty experienced during specific functional activities related to the temporomandibular joint. This measure will assess the impact of the intervention on improving jaw function in patients with temporomandibular disorders.

    Measured: Jaw functional disability will be assessed at baseline (pre-intervention) and after the 4-week intervention (post-intervention).

  4. Oral behaviors

    Oral behaviors will be evaluated using the Oral Behavior Checklist (OBC), a validated self-report questionnaire designed to assess the frequency and type of oral behaviors during waking hours and sleep. This includes activities such as clenching, grinding, and other parafunctional habits that may influence temporomandibular disorder symptoms. The OBC will help determine changes in oral behaviors as a result of the intervention.

    Measured: Oral behaviors will be assessed at baseline (pre-intervention) and after the 4-week intervention (post-intervention).

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 May 2025
  2. Study start7 Aug 2023
  3. Primary completion30 Oct 2024
  4. Study completion24 Dec 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Non-randomised
Intervention model
Single group
Model description
A single group of participants received the intervention. Outcomes were measured before and after the intervention within the same group to assess changes over time
Masking
None (open label)
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06994910
Sponsor's protocol ID
CAMS/PTBR/3/127
Acronym
TMD/VAS/ROM
Status last verified
May 2025
First submitted
20 May 2025
Last updated
29 May 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: De-identified individual participant data (IPD) will be shared for research purposes.

Questions about this trial

What is this clinical trial studying?

A study testing Maitland mobilization techniques in people with Temporomandibular Disorders (TMD), run by Palestine Polytechnic University at 1 site in Palestinian Territories.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 May 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Palestinian Territories. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain intensity (time frame: Pain will be measured at baseline (pre-intervention) and after completion of the 4-week intervention (post-intervention)). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 May 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in